EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseÜbersichtsarbeitOpen Access · CC BY 4.0

PD-(L)1 containing rechallenge strategies in patients with advanced NSCLC previously treated with immunotherapy: A systematic review and meta-analysis across resistance phenotypes

Daniele Marinelli, Fabrizio Citarella, Andrea Torchia, Sagal Pannu, Ayesha Aijaz, Luisana Sisca, Marco Russano, Yu Fujiwara, Kazuki Takada, Amin H Nassar, Giuseppe Luigi Banna, Biagio Ricciuti und 17 weitere

Cancer Treatment Reviews · 2026-06 · 147 · 103159

DOI: 10.1016/j.ctrv.2026.103159 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Cancer Treatment Reviews, 2026-06. Verfasst von Daniele Marinelli und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Medicine, Sapienza University, Rome, Italy; Department of Medical Oncology 2, IRCCS "Regina Elena" National Cancer Institu…. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Drug Resistance, Neoplasm, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsCarcinoma, Non-Small-Cell LungDrug Resistance, NeoplasmImmune Checkpoint InhibitorsB7-H1 AntigenHumansImmunotherapyPhenotypeRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

Acquired resistanceDocetaxelImmune checkpoint inhibitor resistanceImmunotherapy rechallengeNon-small-cell lung cancerPD-(L)1 inhibitorsPrimary resistanceSecond-line therapy

Substanzen

Immune Checkpoint InhibitorsB7-H1 AntigenCD274 protein, human

Autor:innen und Institutionen

  • Department of Experimental Medicine, Sapienza University, Rome, Italy; Department of Medical Oncology 2, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
  • Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo 200, 00128 Roma, Italy.
  • Department of Medical Oncology 2, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy; Clinical and Molecular Medicine, Sapienza - Università di Roma, Rome, Italy.
  • Stephenson Cancer Center, University of Oklahoma, Oklahoma City, OK, the United States of America.
  • Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo 200, 00128 Roma, Italy; Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medi…
  • Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, the United States of America; Department of Clinical Oncology, Institute of Science Tokyo, Tokyo 1138510, Japan.

Zitieren

APA

Marinelli, D., Citarella, F., Torchia, A., Pannu, S., Aijaz, A., Sisca, L., Russano, M., Fujiwara, Y., Takada, K., Nassar, A. H., Banna, G. L., Ricciuti, B., Brunetti, L., Santo, V., Passaro, A., Saw, S. P. L., Li, M. S. C., Addeo, A., Ferrara, R., …, & Cortellini, A. (2026). PD-(L)1 containing rechallenge strategies in patients with advanced NSCLC previously treated with immunotherapy: A systematic review and meta-analysis across resistance phenotypes. Cancer Treatment Reviews, 147, 103159. https://doi.org/10.1016/j.ctrv.2026.103159

Vancouver

Marinelli D, Citarella F, Torchia A, Pannu S, Aijaz A, Sisca L, et al. PD-(L)1 containing rechallenge strategies in patients with advanced NSCLC previously treated with immunotherapy: A systematic review and meta-analysis across resistance phenotypes. Cancer Treatment Reviews. 2026;147:103159. doi:10.1016/j.ctrv.2026.103159

BibTeX
@article{Marinelli2026,
  author = {Marinelli, Daniele and Citarella, Fabrizio and Torchia, Andrea and Pannu, Sagal and Aijaz, Ayesha and Sisca, Luisana and Russano, Marco and Fujiwara, Yu and Takada, Kazuki and Nassar, Amin H and Banna, Giuseppe Luigi and Ricciuti, Biagio and Brunetti, Leonardo and Santo, Valentina and Passaro, Antonio and Saw, Stephanie P L and Li, Molly S C and Addeo, Alfredo and Ferrara, Roberto and Di Maio, Massimo and Mountzios, Giannis and Santini, Daniele and Maugeri-Saccà, Marcello and Vincenzi, Bruno and Acker, Fabian and Reckamp, Karen L and Cappuzzo, Federico and Naqash, Abdul Rafeh and Cortellini, Alessio},
  title = {PD-(L)1 containing rechallenge strategies in patients with advanced NSCLC previously treated with immunotherapy: A systematic review and meta-analysis across resistance phenotypes},
  journal = {Cancer Treatment Reviews},
  year = {2026},
  volume = {147},
  pages = {103159},
  doi = {10.1016/j.ctrv.2026.103159}
}
Kostenlos starten →